Compare Nvidia Corp (NVDA) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nvidia Corp vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? Nvidia Corp trades at $234.46 (market cap $5.73T), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.27 (market cap $2.28B). The key difference: Nvidia Corp is far larger — about 2513.2× SELLAS Life Sciences Group Inc. Common Stock's market cap, and Nvidia Corp pays a 0.42% dividend while SELLAS Life Sciences Group Inc. Common Stock pays none. Which is the better fit depends on your goals.
| NVDA | SLS | |
|---|---|---|
Market Cap | $5.73T | $2.28B |
Volume | 81,027,431 | 3,128,960 |
Sector | Technology | Health |
52-Week High | $239.27 | $15.46 |
52-Week Low | $165.17 | $1.39 |
Typical Hold Time | 115 Days | — |
Enterprise Value | $5.71T | $2.15B |
Dividend Yield | 0.42% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NVIDIA (NVDA) trades at $237.36, down 0.8% on the day, amid strong fundamental performance with revenue surging to $130.5 billion in 2025 and net income reaching $72.88 billion. The stock maintains a bullish technical outlook with moving averages signaling strength, though RSI levels suggest potential overbought conditions. Recent earnings beats and a 75.95% analyst buy rating support positive sentiment, while the company's dominant position in AI chips drives continued growth expectations.
Outlook remains positive with a consensus price target of $339.17 representing significant upside potential. Key opportunities include sustained AI demand and expanding market leadership, while risks involve increased competition, peak AI spending concerns, and valuation metrics above industry averages. The stock's current valuation reflects high growth expectations that must be met to justify further appreciation.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nvidia Corp
NVIDIA Corporation designs, develops, and markets three dimensional (3D) graphics processors and related software. The Company offers products that provides interactive 3D graphics to the mainstream personal computer market.
Read more on NVDA →About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →
